Mid-Urethral Sling Market Research Report Information by Product Type (Tension-free Vaginal Tape (TVT) Slings and Transobturator (TOT) Slings), Indication (Stress Urinary Incontinence (SUI) [Type I, Type II, and Type III], and Mixed Urinary Incontinence (MUI)), by end user (Hospitals and Clinics, Ambulatory Surgical Centers, and Others) and By Region (North America, Europe, Asia-Pacific, And Rest of The World) - Forecast Till 2032

Global Mid-Urethral Sling Market Overview

The Mid-Urethral Sling Market size was valued at USD 1.21 billion in 2023 and is projected to grow from USD 1.27 Billion in 2024 to USD 2.03 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.40% during the forecast period (2024 - 2032). The rising prevalence of urinary incontinence and the increasing geriatric population are driving the market growth.  

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Mid-Urethral Sling Market Trends

• Rising prevalence of urinary incontinence to boost the market growth.

Urinary incontinence has become more common in recent years because of several reasons such as urinary tract infections, neurological problems, obesity, and pelvic floor issues. The increased incidence of urine incontinence has fueled market expansion as more patients seek additional treatments and supplies to control their symptoms. According to the European Commission, over 56 million individuals will be affected by urinary incontinence by 2023.

Furthermore, the increased demand for incontinence products and treatments has presented producers with chances to develop products that are most suited to patients' needs. Companies such as Coloplast, Inc. (US), Boston Scientific Corporation (US), and Cook Medical (US) are investing in the development and manufacture of advanced incontinence management products such as mid-urethral slings and others to capitalize on the increasing demand from the patient population, which is propelling the market's growth.

Mid-Urethral Sling Market Segment Insights

Mid-Urethral Sling Product Type Insights

The Mid-Urethral Sling Market segmentation, based on product type includes Tension-free Vaginal Tape (TVT) Slings and Transobturator (TOT) Slings. The Tension-free Vaginal Tape (TVT) Slings segment is to hold the majority share in 2022 in the Mid-Urethral Sling Market revenue. This is due to the rising aging population, along with an increasing number of women seeking treatment for urinary incontinence. Moreover, Tension-free Vaginal Tape (TVT) slings is used for the treatment of female stress urinary incontinence. The first procedure to be used to treat stress incontinence was the retropubic method, often known as Tension-free Vaginal Tape (TVT).

September 2021: Urocure (US) announced a partnership agreement with LiNA Medical which is specifying in minimally invasive medical devices in the fields of gynecology and urology. As per the partnership agreement company developed products for women’s health.

Mid-Urethral Sling Market, by Product Type, 2023 & 2032 (USD Billion)

Source: Secondary Research, Primary Research, MRFR Database and Analyst Review

Mid-Urethral Sling Indication Insights

The Mid-Urethral Sling Market segmentation is based on an indication that includes Stress Urinary Incontinence (SUI) and Mixed Urinary Incontinence (MUI).  Further, Stress Urinary Incontinence (SUI) is further segmented into Type I, Type II, and Type III. The Stress Urinary Incontinence (SUI) segment dominated the market in 2022 with respect to the Mid-Urethral Sling Market revenue. This is due to the technological innovations in surgical techniques, materials, and instruments improving the safety and efficiency of SUI treatment options, increasing aging populations, and rising female prevalence. Thus, growing acceptance of these procedures and rising government initiatives & campaigns aimed at raising awareness about urinary incontinence have encouraged individuals to seek treatment, positively impacting the market's expansion.

Mid-Urethral Sling End User Insights

The Mid-Urethral Sling Market segmentation is based on an end user that includes hospitals and clinics, ambulatory surgical centers, and others. The hospitals and clinics segment dominated the market in 2022 with respect to the Mid-Urethral Sling Market revenue. This is due to the availability of comprehensive medical resources, including skilled medical professionals, advanced surgical equipment, and support services. Moreover, the rising number of multispecialty & community hospitals across the globe and increasing healthcare expenditure are also boosting the hospitals & clinics segment in the forecast period.

Mid-Urethral Sling Regional Insights

By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. North America mid-urethral sling held the largest market share in 2022. This is attributed to the increasing cases of stress urinary incontinence (SUI) in women, high preference for minimally invasive sling procedures, and rising prevalence of neurological disorders such as multiple sclerosis and Parkinson's disease. Further, the major countries studied are the US, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil. Moreover, the high adoption of technologically advanced products and the growing incidence of chronic diseases such as stroke and diabetes are expected to fuel regional market growth.

Figure 3: MID-URETHRAL SLING MARKET SHARE BY REGION 2022 & 2032

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Europe mid-urethral sling market accounts for the second-largest market share due to the high incidence of neurological disorders in European countries such as dementia, stroke, and Alzheimer's diseases, increased incidence of stress urinary incontinence among women, and the presence of major market players in the region. Further, the Germany mid-urethral sling market held the largest market share, and the UK mid-urethral sling market was the fastest-growing market in the European region.

The Asia-Pacific mid-urethral sling market is expected to grow at a significant growth rate during the forecast period. This is due to an increasing number of cesarean deliveries and increasing incidence of obesity and diabetes are some of the factors contributing to the growth of the Asia-Pacific regional market. In addition, the increasing availability of medical coverage for stress urinary incontinence (SUI) is projected to attract foreign investments in this region. Moreover, the China mid-urethral sling market held the largest market share, and the India mid-urethral sling market was the fastest-growing market in the Asia-Pacific region.

Mid-Urethral Sling Key Market Players & Competitive Insights

The Mid-Urethral Sling Market is characterized by the presence of many global, regional, and local vendors catering to the demand created by research scientists and pharmaceutical and biotechnology companies operating in the industry. The market comprises tier-1, tier-2, and local players. The tier-1 and tier-2 players have reached across the globe with diverse product portfolios. Companies such as Boston Scientific Corporation (US), Coloplast Corp (Denmark), CALDERA MEDICAL (US), and UroCure (US) dominate the Mid-Urethral Sling Market due to product differentiation, financial stability, strategic developments, and diversified regional presence. The players are focused on investing in extensive research and development as well. Furthermore, they adopt strategic growth initiatives, such as expansion, product launches, joint ventures, and partnerships, to strengthen their market position and capture a large customer base.

Caldera Medical (US) is a manufacturer and supplier of medical equipment. The company provides the best surgical equipment for treating stress, urinary incontinence, and pelvic organ prolapse. The company's implants offer mesh integrity in a versatile, user-friendly system that can be used with different surgical approaches, such as transvaginal, suprapubic, and transobturator, enabling doctors to treat female patients with the least amount of invasive surgery feasible. By 2025, Caldera Medical, in partnership with its surgeon clients, aims to treat one million women in underserved populations globally, the largest humanitarian project of any women's health company. The company serves its customers across the globe. For Instance, in December 2021, The US Food and Drug Administration (FDA) approved its certification of Caldera Medical's Desara TVez sling system. A transvaginal sling device Desara TVez sling is used to treat female stress urine incontinence (SUI). In addition, the company offers the widest range of treatment choices for women with stress urinary incontinence because of approval. Additionally, the company cultivates strong relationships with surgeons to enhance its products through efficient engagement and collaboration.

Also, Johnson & Johnson Services, Inc. (US) manufactures medical devices, pharmaceuticals, and consumer packaged goods. The company offers medical devices for various specialties such as orthopedics and cardiovascular diseases. The firm has its research facilities in the US, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland, and the UK. The company global market presence in over 175 countries as well as a strong distribution network in North America, Europe, Asia-Pacific, and the Rest of the World.

Key Companies in the Mid-Urethral Sling Market Include.

• Boston Scientific Corporation (US)


• Coloplast Corp (Denmark)


• MEDI TECH DEVICES PVT LTD (India)


• Promedon S.A (Argentina)


• CALDERA MEDICAL (US)


• M.I. GmbH (Austria)


• Johnson & Johnson Services, Inc (US)


• Betatech Medical (Turkey)


• UroCure (US)


• Global Medi Innovations (India)


• Bıçakcılar (Türkiye)


• Advin Health Care (India)


• Lotus Surgicals (India)


• Biorad Medisys Pvt Ltd (India)


• Genev (India)

Mid-Urethral Sling Market Segmentation

Mid-Urethral Sling Product Type Outlook

• Tension-free Vaginal Tape (TVT) Slings


• Transobturator (TOT) Slings

Mid-Urethral Sling Indication Outlook

• Stress Urinary Incontinence (SUI)
  
  
  
  • Type I
  
  
  • Type II
  
  
  • Type III
  
  
  
  


• Mixed Urinary Incontinence (MUI)

Mid-Urethral Sling End User Outlook

• Hospitals and Clinics


• Ambulatory Surgical Centers


• Others

Mid-Urethral Sling Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America